Skip to Main Content

Paper Details

Rationale and Design of ORCHID: A Randomized Placebo-controlled Clinical Trial of Hydroxychloroquine for Adults Hospitalized with COVID-19.
Ann Am Thorac Soc
23
2020
Adults, COVID-19, Hydroxychloroquine, coronavirus disease, hydroxychloroquine, patient, patients
Adult, Antimalarials, Betacoronavirus, COVID-19, Coronavirus Infections, Dose-Response Relationship, Drug, Hospitalization, Humans, Hydroxychloroquine, Pandemics, Pneumonia, Viral, SARS-CoV-2, Single-Blind Method, Treatment Outcome
Author NameAffiliation
Jonathan D Casey
Nicholas J Johnson
Nicholas J JohnsonHarborview Medical Center
Matthew W Semler
Sean P Collins
Neil R AggarwalLung and Blood Institute
Roy G BrowerJohns Hopkins University
Steven Y Changuniversity of california los angeles David Geffen School of Medicine
John EppensteinerDuke University
Michael R Filbin
Kevin W GibbsWake Forest School of Medicine
Adit A Ginde
Michelle N GongMontefiore Medical Center, Albert Einstein College of Medicine
Frank E HarrellVanderbilt University School of Medicine
Douglas Hayden
Catherine L HoughHarborview Medical Center
Akram KhanOregon Health and Science University School of Medicine
Lindsay M LeitherIntermountain Medical Center and University of Utah
Marc MossUniversity of Colorado School of Medicine
Cathryn F Oldmixon
Pauline K ParkUniversity of Michigan ann arbor
Lora A ReineckLung and Blood Institute
Nancy J Ringwood
Bryce R H RobinsonUniversity of Washington
David A Schoenfeld
Nathan I ShapiroBeth Israel Deaconess Medical Center and Harvard Medical School
Jay S SteingrubUniversity of Massachusetts Medical School-Baystate
Donna K TorrDepartment of Pharmacy Services, Vanderbilt University Medical Center
Alexandra WeissmanUniversity of Pittsburgh
Christopher J LindsellVanderbilt University School of Medicine
Todd W Rice
Boyd Taylor ThompsonMassachusetts General Hospital
Samuel M BrownIntermountain Medical Center and University of Utah
Wesley H Self
  • 1 - 34

Datasets

Release 1.2